GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 34601 - 34650 of 39437 in total
PDB ID ▲ UniProt ID Title Descriptor
8DTC L8GT25 Crystal Structure of Glucokinase with bound glucose from Acanthamoeba castellanii
8DTK P0DTC2 Structure of RBD directed antibody DH1047 in complex with SARS-CoV-2 spike: Local refinement of RBD-Fab interace
8DTK 8DTK Structure of RBD directed antibody DH1047 in complex with SARS-CoV-2 spike: Local refinement of RBD-Fab interace
8DTO 8DTO Vaccine elicited Antibody MU89 bound to CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 Env trimer
8DU5 O35657 Murine sialidase-1 (NEU1)
8DUA V9PL68 SIV E660.CR54 SOS-2P Env Trimer with ITS92.02
8DUA C4NR77 SIV E660.CR54 SOS-2P Env Trimer with ITS92.02
8DUA 8DUA SIV E660.CR54 SOS-2P Env Trimer with ITS92.02
8DUL P13897 Cryo-EM Structure of Antibody SKT05 in complex with Western Equine Encephalitis Virus spike (local refinement from VLP particles)
8DUL 8DUL Cryo-EM Structure of Antibody SKT05 in complex with Western Equine Encephalitis Virus spike (local refinement from VLP particles)
8DUN P13897 Cryo-EM Structure of Antibody SKW11 in complex with Western Equine Encephalitis Virus spike (local refinement from VLP particles)
8DUN 8DUN Cryo-EM Structure of Antibody SKW11 in complex with Western Equine Encephalitis Virus spike (local refinement from VLP particles)
8DV1 P0DTC2 SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to linker variant of affinity matured ACE2 mimetic CVD432
8DV1 P0DOX5 SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to linker variant of affinity matured ACE2 mimetic CVD432
8DV1 Q9BYF1 SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to linker variant of affinity matured ACE2 mimetic CVD432
8DV2 P0DTC2 SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to computationally engineered ACE2 mimetic CVD293
8DV2 P0DOX5 SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to computationally engineered ACE2 mimetic CVD293
8DV2 Q9BYF1 SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to computationally engineered ACE2 mimetic CVD293
8DV3 P29016 Crystal structure of human CD1b presenting Phosphatidylinositol C34:1
8DV3 P61769 Crystal structure of human CD1b presenting Phosphatidylinositol C34:1
8DV4 P29016 Crystal structure of the BC8B TCR-CD1b-PI complex
8DV4 P61769 Crystal structure of the BC8B TCR-CD1b-PI complex
8DV4 8DV4 Crystal structure of the BC8B TCR-CD1b-PI complex
8DVD A0A0C5JYT4 Cryo-EM structure of SIVmac239 SOS-2P Env trimer in complex with human bNAb PGT145
8DVD A0A4Y5TGK0 Cryo-EM structure of SIVmac239 SOS-2P Env trimer in complex with human bNAb PGT145
8DVD 8DVD Cryo-EM structure of SIVmac239 SOS-2P Env trimer in complex with human bNAb PGT145
8DVL O75581 Crystal structure of LRP6 E3E4 in complex with disulfide constrained peptide E3.18
8DVL 8DVL Crystal structure of LRP6 E3E4 in complex with disulfide constrained peptide E3.18
8DVM O75581 Crystal structure of LRP6 E3E4 in complex with disulfide constrained peptide E3.6
8DVM 8DVM Crystal structure of LRP6 E3E4 in complex with disulfide constrained peptide E3.6
8DVN O75581 Crystal structure of LRP6 E3E4 in complex with disulfide constrained peptide E3.10
8DVN 8DVN Crystal structure of LRP6 E3E4 in complex with disulfide constrained peptide E3.10
8DW2 8DW2 Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR22, and two antibody Fabs, S309 and CR3022
8DW2 P0DTC2 Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR22, and two antibody Fabs, S309 and CR3022
8DW3 8DW3 Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR16m, and two antibody Fabs, S309 and CR3022
8DW3 P0DTC2 Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR16m, and two antibody Fabs, S309 and CR3022
8DWA P0DTC2 Crystal structure of neutralizing antibody P1D9 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD)
8DWA 8DWA Crystal structure of neutralizing antibody P1D9 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD)
8DWB Q8AZ87 Neuraminidase from influenza virus A/Moscow/10/1999(H3N2) in complex with sialic acid
8DWD P83847 Adenine glycosylase MutY variant E43S in complex with DNA containing d(8-oxo-G) paired with an AP site generated by the enzyme acting on purine
8DWW Q5XXP3 Chikungunya VLP in complex with neutralizing Fab 506.A08 (asymmetric unit)
8DWW 8DWW Chikungunya VLP in complex with neutralizing Fab 506.A08 (asymmetric unit)
8DWX Q5XXP3 Chikungunya VLP in complex with neutralizing Fab 506.C01 (asymmetric unit)
8DWX 8DWX Chikungunya VLP in complex with neutralizing Fab 506.C01 (asymmetric unit)
8DWY Q5XXP3 Chikungunya VLP in complex with neutralizing Fab CHK-265 (asymmetric unit)
8DWY 8DWY Chikungunya VLP in complex with neutralizing Fab CHK-265 (asymmetric unit)
8DXS P0DTC2 Cryo-EM structure of RBD-directed neutralizing antibody P2B4 in complex with prefusion SARS-CoV-2 spike glycoprotein
8DXS 8DXS Cryo-EM structure of RBD-directed neutralizing antibody P2B4 in complex with prefusion SARS-CoV-2 spike glycoprotein
8DXT 8DXT Fab arm of antibody GAR12 bound to the receptor binding domain of SARS-CoV-2.
8DXT P0DTC2 Fab arm of antibody GAR12 bound to the receptor binding domain of SARS-CoV-2.

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024